April 8, 2025, 12:20 pm
A digital health startup has finalized a major acquisition by taking Accolade private in a deal valued at $621 million. Spearheaded by its CEO—whose previous leadership at Livongo culminated in a high-profile acquisition by Teladoc—the move is set to reshape competitive dynamics in the digital healthcare sector. The privatization is expected to streamline decision-making, boost innovation, and expand integrated wellness solutions, reinforcing the company's strategic commitment to advancing health technology services.
Accolade shareholders will receive US$7.03 per share in cash following the acquisition by Transcarent.
Transcarent CEO Glen Tullman previously led Livongo, which was purchased by Teladoc in a 2020 agreement that valued the company at $18.5 billion.
2 stories from 2 sources in 7 days ago ... #startups #vc #digitalhealth
Figma Launches IPO Filing After Abandoning Adobe Deal (9 hours ago)
OpenAI develops X-like social media network prototype (14 hours ago)
UK Insurtech Marshmallow Secures $90M Funding at $2B Valuation (23 hours ago)
Figma Launches IPO Filing After Abandoning Adobe Deal (9 hours ago)
UK Insurtech Marshmallow Secures $90M Funding at $2B Valuation (23 hours ago)
Intel Sells Majority Stake in Altera to Private Equity Firms (32 hours ago)
The Last of Us Season 2 reveals major narrative twists and character arcs (40 hours ago)
Apple Celebrates 10 Years of Apple Watch Activity Rings (41 hours ago)
UnitedHealth Launches Aggressive Effort to Recoup Physician Loans Post Cyberattack (4 days ago)
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.